[Effective June 1st] FY2026 Medical Fee Revision – Summary of Notifications, Interpretation of Doubts, Official Gazette Corrections, etc. – PT-OT

News Highlights

The FY2026 medical fee revision became effective on June 1st. PT-OT-ST.NET is providing information for medical institution managers and successors by organizing notifications, interpretations of doubts, and official gazette corrections related to this revision. Points for M&A and business succession are suggested, such as management and succession strategies considering the revision cycle, maintaining facility standards through economies of scale and dispersing equipment investment burdens, and utilizing tax incentives through conversion to specific medical corporations or social medical corporations.

M&A Medical Editorial Department's Perspective

6月1日施行の令和8年度診療報酬改定は、単なる診療報酬の増減に留まらず、医療機関の経営戦略、特に事業承継のあり方に深く影響を与える。PT-OT-ST.NETが指摘する「規模のメリット」は、診療報酬改定で示される施設基準の維持や、高額化する医療機器への設備投資負担を分散する上で、グループ化が有効な選択肢となり得ることを示唆している。例えば、小規模なクリニックや病院が、地域包括ケアシステム構築を推進する医療法人グループに参画することで、単独では維持困難な高度な医療機能や、将来的な設備更新への対応が可能になる。さらに、特定医療法人や社会医療法人への移行を見据えた税務スキームの活用は、承継時の税負担を軽減し、円滑な事業承継を実現する上で極めて重要だ。今回の改定は、将来的な収益性や事業継続性を鑑みた、より戦略的なM&A・承継の必要性を浮き彫りにしていると言える。

Points Raised by This News

• The medical fee revision suggests changes in the revenue structure according to the scale and function of medical institutions, potentially increasing the need for scale expansion through M&A.
• From the perspective of maintaining facility standards and dispersing equipment investment burdens, joining a medical corporation group becomes an effective option to overcome the limitations of independent management.
• Tax schemes aimed at transitioning to specific medical corporations or social medical corporations directly reduce tax burdens during succession, enhancing the feasibility of business succession.
• The FY2026 revision serves as an opportunity to reconsider the sustainability of medical institutions and business succession strategies from a longer-term perspective.

Practical Questions Arising from This News

• How will the specific medical departments of our hospital be affected by this medical fee revision?
• Are there any applicable schemes for our hospital's situation regarding tax incentives through group affiliation or corporate conversion?
• Based on the revision details, how can we balance future equipment investment plans with our business succession plan?

If You Feel "Should I Consult Too?"

For managers and successors who feel anxious about their hospital's revenue structure and future management strategy due to this medical fee revision, this is a good opportunity to consider options such as M&A, corporate consolidation, or conversion. In particular, maintaining facility standards indicated by the revision, addressing high-cost equipment investments, and utilizing tax schemes for smooth business succession require specialized knowledge. We recommend comparing your hospital's current situation with its future vision and consulting with experts early on to determine whether maintaining the status quo is the best option, or if new partnerships or organizational restructuring would be effective.

M&A Medical (CentralMedience Inc.) is a business succession support service for medical corporations, hospitals, and clinics, certified by the Small and Medium Enterprise Agency as an M&A support institution. We provide comprehensive support.Success FeeWe handle consultations with strict confidentiality.Contact Us for a Free Consultation